Zevra Therapeutics Executives Sell Shares Amid Ongoing Trading Activity

Zevra Therapeutics, Inc. (ZVRA) has announced that Neil F. McFarlane, Director, President, and CEO, has sold 91,000 shares at $9.38 per share on February 2, 2026. Additionally, Adrian W. Quartel, Chief Medical Officer, has sold 4,533 shares at $8.83 per share on January 30, 2026, while Timothy J. Sangiovanni, SVP, Finance & Corp Controller, has sold 1,750 shares at $8.82 per share on the same day. Joshua Schafer, CCO, has also sold 3,375 shares at $8.83 per share on January 30, 2026, and Rahsaan Thompson, Chief Legal & Compliance, has sold 4,080 shares at $8.83 per share on January 30, 2026.